YTHDF1 and breast carcinoma: The results showed that the effect of miR-16-5p treatment was similar to that of shRNA-YTHDF1 mediated YTHDF1 silencing effectively abolishing the growth and lung metastasis of subcutaneous breast cancer in mice.